Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin + Amlodipine vs Amlodipine in Hyperlipidemia and Hypertension
NCT00174330Phase 4Completed
- Sponsor
- Viatris
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atorvastatin in hyperlipidemia (2 arms), sponsored by Viatris. Primary endpoint: Efficacy of Dual Therapy vs Monotherapy. Started May 2005; status: completed.
02
Drugs
atorvastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT00174330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174330.